Hoth Therapeutics, Inc. (NASDAQ: HOTH) Issues Letter to Shareholders
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today issued a letter to shareholders. Dear Shareholder, I […]
